Description

Anastrozole

Aromatase Inhibitor Research Compound

Anastrozole is a potent, selective, nonsteroidal aromatase inhibitor (AI) extensively studied for its ability to inhibit the conversion of androgens into estrogens.

By targeting the aromatase enzyme, anastrozole provides researchers with a well-characterized compound for investigating estrogen biosynthesis, endocrine signaling, aromatase activity, and hormone-dependent biological pathways.

How Anastrozole Works

Aromatase (CYP19A1) is an enzyme responsible for converting certain androgens into estrogens, including the conversion of testosterone to estradiol and androstenedione to estrone.

Anastrozole binds reversibly to aromatase and inhibits its activity, resulting in decreased estrogen synthesis.

This mechanism has made anastrozole an important compound in research involving:

• Aromatase inhibition
• Estrogen biosynthesis
• Androgen-to-estrogen conversion
• Estradiol regulation
• Endocrine signaling
• Hormone-responsive cellular pathways

Key Characteristics

Potent Aromatase Inhibition
Anastrozole is a highly effective inhibitor of the aromatase enzyme and has been extensively characterized in pharmacological research.

Nonsteroidal Structure
Unlike steroidal aromatase inhibitors, anastrozole is classified as a nonsteroidal aromatase inhibitor.

Long Elimination Half-Life
Anastrozole has an approximate terminal elimination half-life of 40–50 hours, allowing sustained aromatase inhibition.

Well-Characterized Pharmacology
Decades of clinical and laboratory investigation have produced extensive scientific literature regarding its pharmacokinetics, endocrine effects, and mechanism of action.

Research Areas

Anastrozole has been investigated in research involving:

• Aromatase enzyme activity
• Estrogen synthesis and metabolism
• Estradiol regulation
• Endocrine feedback mechanisms
• Androgen/estrogen balance
• Hormone-responsive cellular pathways
• Breast cancer biology
• Reproductive endocrinology
• CYP19A1 research

Compound Information

Compound: Anastrozole
Compound Class: Nonsteroidal Aromatase Inhibitor
Molecular Formula: C₁₇H₁₉N₅
Molecular Weight: 293.37 g/mol
Approximate Half-Life: 40–50 hours
Primary Target: Aromatase (CYP19A1)

Anastrozole vs. Other Aromatase Inhibitors

Anastrozole belongs to the same general pharmacological class as letrozole, with both acting as nonsteroidal aromatase inhibitors. It differs mechanistically from steroidal aromatase inhibitors such as exemestane, which irreversibly inactivates aromatase.

These differences make the compounds useful for investigating different approaches to aromatase inhibition and estrogen regulation.

Notice & Acknowledgement